GARREN; Hideki

Patent Applications and Registrations

Patent applications and USPTO patent grants for GARREN; Hideki.The latest application filed is for "method for treating multiple sclerosis".

Company Profile

1.10.22

GARREN; Hideki - Palo Alto CA
Garren; Hideki - Stanford CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Treating Multiple Sclerosis App 20210388099 - LEPPERT; David ; et al.	2021-12-16
Compositions And Methods For Treatment Of Type 1 Diabetes App 20190315827 - Roep; Bart O. ; et al.	2019-10-17
Method For Treating Multiple Sclerosis App 20180327505 - LEPPERT; David ; et al.	2018-11-15
Compositions And Methods For Treatment Of Insulin-dependent Diabetes Mellitus App 20180092991 - Garren; Hideki ; et al.	2018-04-05
Compositions And Methods For Treatment Of Type 1 Diabetes App 20160068585 - Roep; Bart O. ; et al.	2016-03-10
DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus Grant 8,748,404 - Steinman , et al. June 10, 2	2014-06-10
DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus App 20110034543 - STEINMAN; LAWRENCE ; et al.	2011-02-10
Nogo epitopic fragments for modulating immune response Grant 7,867,976 - Steinman , et al. January 11, 2	2011-01-11
Therapeutic And Diagnostic Uses Of Antibody Specificity Profiles App 20100330110 - Robinson; William H. ; et al.	2010-12-30
Methods and immune modulatory nucleic acid compositions for preventing and treating disease Grant 7,811,813 - Garren , et al. October 12, 2	2010-10-12
Therapeutic and diagnostic uses of antibody specificity profiles Grant 7,785,819 - Robinson , et al. August 31, 2	2010-08-31
Compositions And Methods For Treatment Of Autoimmune Disease App 20100160415 - Solvason; Nanette ; et al.	2010-06-24
Methods And Immune Modulator Nucleic Acid Compositions For Preventing And Treating Disease App 20100130593 - Garren; Hideki ; et al.	2010-05-27
DNA vaccination for treatment of autoimmune disease Grant 7,704,970 - Steinman , et al. April 27, 2	2010-04-27
Polynucleotide Therapy App 20100048679 - Garren; Hideki ; et al.	2010-02-25
Polynucleotide Therapy App 20090281170 - Fontoura; Paulo ; et al.	2009-11-12
Polynucleotide Therapy App 20090264515 - Fontoura; Paulo ; et al.	2009-10-22
Treatment of demyelinating autoimmune disease with modified ordered peptides Grant 7,585,843 - Garren , et al. September 8, 2	2009-09-08
DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus Grant 7,579,328 - Steinman , et al. August 25, 2	2009-08-25
Polynucleotide therapy Grant 7,544,669 - Fontoura , et al. June 9, 2	2009-06-09
Dna Vaccination For Treatment Of Autoimmune Disease App 20080108585 - Steinman; Lawrence ; et al.	2008-05-08
Novel Immunomodulating Peptide App 20070280954 - Steinman; Lawrence ; et al.	2007-12-06
Treatment Of Demyelinating Autoimmune Disease with Modified Ordered Peptides App 20070275899 - Garren; Hideki ; et al.	2007-11-29
DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus App 20060084623 - Steinman; Lawrence ; et al.	2006-04-20
DNA vaccination for treatment of autoimmune disease Grant 7,030,098 - Steinman , et al. April 18, 2	2006-04-18
Methods and immune modulatory nucleic acid compositions for preventing and treating disease App 20050261215 - Garren, Hideki ; et al.	2005-11-24
Use of statins and other immunomodulatory agents in the treatment of autoimmune disease App 20030229044 - Steinman, Lawrence ; et al.	2003-12-11
Polynucleotide therapy App 20030148983 - Fontoura, Paulo ; et al.	2003-08-07
Therapeutic and diagnostic uses of antibody specificity profiles App 20030003516 - Robinson, William H. ; et al.	2003-01-02
DNA vaccination for treatment of autoimmune disease App 20020068715 - Steinman, Lawrence ; et al.	2002-06-06

Company Registrations

NCAGE Code	44JN4	GARREN HIDEKI
CAGE Code	44JN4	GARREN, HIDEKI
DUNS	604023247	GARREN, HIDEKI

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.